Brian Harrell, MD
Sports Medicine · Lake Charles, LANPI 1770613705
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,950 of the $2,406 with a category attached, or 81.1%. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 81.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $2,092 and has fallen 96.7% since, to $68 in 2025. That places this record below the midpoint for sports medicine clinicians in LA, where the typical reported total is $3,045.
Across 25 payments — averaging $96.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Intuitive Surgical$70
- Astellas Pharma US Inc$64
- Johnson & Johnson$52
- Novo Nordisk$44
- Gilead$37
- plus $189 from 10 others
What the payments were for
- Speaking & faculty fees$1,95081%
- Food & beverage$45619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,406 in reported general payments places this provider in the 45th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $33,713 |
| Potassium Chloride | 25 | $890 |
| Levothyroxine Sodium | 45 | $778 |
| Atorvastatin Calcium | 35 | $499 |
| Gabapentin | 27 | $489 |
| Omeprazole | 23 | $462 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $445 |
| Losartan Potassium | 30 | $407 |
| Spironolactone | 13 | $390 |
| Lisinopril | 39 | $356 |
| Hydroxychloroquine Sulfate | 12 | $352 |
| Duloxetine Hcl | 14 | $347 |
| Amlodipine Besylate | 35 | $328 |
| Fluoxetine Hcl | 11 | $315 |
| Donepezil Hcl | 14 | $305 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Lake Charles
- Brett CascioLake Charles$82K
- Alex AndersonLake Charles$2K
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brian GodshawNew Orleans$69K
- Andrew GottschalkJefferson$45K
- Michael LeddyAlexandria$44K
- Steven JonesHammond$38K
- Mario Lobao GoncalvesShreveport$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.